Kaloyan M. Tsanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaloyan M. Tsanov has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Scott W. Lowe
Memorial Sloan Kettering Cancer Center, New York, NY
39 shared publications - Carlos Carmona-Fontaine
Center for Genomics and Systems Biology, Department of Biology, New York University, New York City, NY, United States of America
33 shared publications - Charles Ng
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
33 shared publications - Craig B. Thompson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
33 shared publications - Francesco V. Cimino
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York
33 shared publications - Manon Ros
Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA
33 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 25 September 2025
- Published by Springer Nature in Nature Cancer
- Vol. 6 (11) , 1839-1856
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
The role of driver gene mutations in sustaining tumor growth at metastatic sites is poorly understood. SMAD4 inactivation is a paradigm of such mutations and a hallmark of pancreatic ductal adenocarcinoma (PDAC). To determine whether metastatic tumors are dependent on SMAD4 inactivation, we developed a mouse model of PDAC that enables spatiotemporal control of Smad4 expression. While Smad4 inactivation in the premalignant pancreas facilitated the formation of primary tumors, Smad4 reactivation in metastatic disease suppressed liver metastases but promoted lung metastases. These divergent effects were underpinned by organ-biased differences in the tumor cells’ chromatin state that emerged in the premalignant pancreas and were distinguished by the dominance of KLF4 versus RUNX1 transcription factors. Our results show how epigenetic states favored by the organ of residence can influence the output of driver mutations in metastatic tumors, which has implications for interpreting tumor genetics and therapeutically targeting metastatic disease.
- 25 September 2025
- Published by Springer Nature in Nature Cancer
- Vol. 6 (11) , 1839-1856
Open AccessSMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
The role of driver gene mutations in sustaining tumor growth at metastatic sites is poorly understood. SMAD4 inactivation is a paradigm of such mutations and a hallmark of pancreatic ductal adenocarcinoma (PDAC). To determine whether metastatic tumors are dependent on SMAD4 inactivation, we developed a mouse model of PDAC that enables spatiotemporal control of Smad4 expression. While Smad4 inactivation in the premalignant pancreas facilitated the formation of primary tumors, Smad4 reactivation in metastatic disease suppressed liver metastases but promoted lung metastases. These divergent effects were underpinned by organ-biased differences in the tumor cells’ chromatin state that emerged in the premalignant pancreas and were distinguished by the dominance of KLF4 versus RUNX1 transcription factors. Our results show how epigenetic states favored by the organ of residence can influence the output of driver mutations in metastatic tumors, which has implications for interpreting tumor genetics and therapeutically targeting metastatic disease.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1